| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
RENAL FUNCTION PANEL
Test CodeLAB19
Quest Code
10314
CPT Codes
80069
Includes
Albumin, BUN/Creatinine Ratio (calculated), Calcium, Carbon Dioxide, Chloride, Creatinine, eGFR (calculated), Glucose, Phosphate (as Phosphorus), Potassium, Sodium, Urea Nitrogen (BUN)
Preferred Specimen
1 mL serum
Patient Preparation
Fasting specimen is preferred
Minimum Volume
0.5 mL
Other Acceptable Specimens
Spun SST tube
Transport Container
Serum separator tube (SST)
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 72 hours
Refrigerated: 72 hours
Frozen: 28 days
Refrigerated: 72 hours
Frozen: 28 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Moderate to gross hemolysis • Red-top tube (no gel) unspun and not separated from cells • Unspun serum separator tube (SST)
Methodology
Ion Selective Electrode (ISE) • Spectrophotometry (SP)
Setup Schedule
Daily
Report Available
1 day
Reference Range
See individual tests
Clinical Significance
This panel is usually ordered to monitor patients with chronic kidney disease (CKD) or as part of a health examination for individuals at high risk of developing kidney diseases [1].
Kidney disease is more likely to develop in individuals with certain conditions, such as high blood pressure, diabetes, heart disease, and a family history of kidney disease. Early symptoms of kidney diseases are often non-specific. This panel is commonly ordered during wellness checks and emergency-room admissions when symptoms and signs are suggestive of kidney diseases. National Kidney Foundation recommends a kidney profile containing estimated glomerular filtration rate and albumin-creatinine ratio for detecting and monitoring CKD [1].
The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.
References
1. Laboratory engagement plan: transforming kidney disease detection. National Kidney Foundation Laboratory Engagement Advisory Group. Published February 2018. Accessed January 6, 2022. https://www.ascp.org/content/docs/default-source/get-involved-pdfs/istp-ckd/laboratory-engagement-plan.pdf
Kidney disease is more likely to develop in individuals with certain conditions, such as high blood pressure, diabetes, heart disease, and a family history of kidney disease. Early symptoms of kidney diseases are often non-specific. This panel is commonly ordered during wellness checks and emergency-room admissions when symptoms and signs are suggestive of kidney diseases. National Kidney Foundation recommends a kidney profile containing estimated glomerular filtration rate and albumin-creatinine ratio for detecting and monitoring CKD [1].
The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.
References
1. Laboratory engagement plan: transforming kidney disease detection. National Kidney Foundation Laboratory Engagement Advisory Group. Published February 2018. Accessed January 6, 2022. https://www.ascp.org/content/docs/default-source/get-involved-pdfs/istp-ckd/laboratory-engagement-plan.pdf
Performing Laboratory
| Quest Diagnostics-Lenexa |
| 10101 Renner Blvd |
| Lenexa , KS 66219-9752 |
Last Updated: August 13, 2021
